Genetic instabilities in human cancers
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Whether and how human tumours are genetically unstable has been debated for decades. There is now evidence that most cancers may indeed be genetically unstable, but that the instability exists at two distinct levels. In a small subset of tumours, the instability is observed at the nucleotide level and results in base substitutions or deletions or insertions of a few nucleotides. In most other cancers, the instability is observed at the chromosome level, resulting in losses and gains of whole chromosomes or large portions thereof. Recognition and comparison of these instabilities are leading to new insights into tumour pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic defects such as DNA mismatch repair deficiencies (dMMR) and microsatellite instability (MSI) predispose tumor cells to the accumulation of somatic mutations and are associated with increased TMB (Lengauer et al., 1998) and increased susceptibility to ICB (Le et al., 2017).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Lengauer et al., 1998
Citations
Cites
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Cited by
Items 801–900 of 1,009
Inhibition of Aurora A in response to DNA damage
Krystyniak, A., Garcı́a-Echeverrı́a, C., Prigent, C., & Ferrari, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209056 · Cited by 96
“Errors in transmission of heritable information derive from problems intrinsic to the machinery dedicated to DNA synthesis and DNA repair, or originate from incorrect segregation of chromatids during mitosis (Lengauer et al., 1998; Loeb et al., 2003).”
BackgroundAddicted to secrete – novel concepts and targets in cancer therapy
Dejeans, N., Manié, S. N., Hetz, C. A., Bard, F., Hupp, T. R., Agostinis, P., Samali, A., & Chevet, É. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.12.003 · Cited by 111
Tanaka, H., & Yao, M.-C. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2591 · Cited by 108
“jpg" NDATA ITEM> ]> Genetic mutations and DNA rearrangements are underlying causes of cance”
BackgroundCook, A. C., Tuck, A. B., McCarthy, S. M., Turner, J. G., Irby, R., Bloom, G. C., Yeatman, T. J., & Chambers, A. F. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20105 · Cited by 106
“Additionally, it has been demonstrated that misregulation of the checkpoint system contributes to an increase in mutability and allows for genetic instability [46].”
BackgroundDeans, B., Griffin, C. S., O’Regan, P., Jasin, M., & Thacker, J. (2003) · PubMed · Cited by 119
RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts
Iovino, F., Lentini, L., Amato, A., & Di Leonardo, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-38 · Cited by 94
“Aneuploidy and its underlying cause (CIN) could be considered a prerequisite in tumor initiation/progression and like alterations in signaling pathways it is believed essential for tumorigenesis [1,2].”
Aneuploidy in the normal and diseased brain
Kingsbury, M. A., Yung, Y. C., Peterson, S. E., Westra, J. W., & Chun, J. J. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6169-5 · Cited by 107
Emergence of a Subpopulation in a Computational Model of Tumor Growth
KANSAL, A. R., Salvatore Torquato, A., Chiocca, E. A., & Deisboeck, T. S. (2000) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.2186 · Cited by 94
“Tumors supposedly harbor cells with an increased mutation rate, which indicates that these tumors are genetically unstable (Nowell, 1976; ( 2000 Academic Press Loeb, 1994; Lengauer et al., 1998).”
BackgroundOral squamous cell carcinoma in relation to field precancerisation: pathobiology
Feller, L., Khammissa, R. A. G., Kramer, B., & Lemmer, J. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-31 · Cited by 122
“mutagens [58], and by ultraviolet-induced helix–distor-”
BackgroundInfluentialThe relationship between aging and carcinogenesis: a critical appraisal
Anisimov, V. N. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00121-x · Cited by 111
“Why is the case? Certainly, aging predisposes cells to accumulate mutations some of which are necessary for initiation of tumorigenesis in target tissues [47,231].”
BackgroundIrving, J. A. E., Bloodworth, L. C., Bown, N. P., Case, M. C., Hogarth, L., & Hall, A. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2604 · Cited by 94
“56,XY,+X,add(1)(q),+6,+9,+12,+14,+17,+21,inc”
BackgroundContinuous hematopoietic cell lines as model systems for leukemia–lymphoma research
Drexler, H. G., Matsuo, Y., & MacLeod, R. A. F. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00070-9 · Cited by 110
“have attempted to show that in colorectal tumors, at least, MSI and CI appear to represent independent tumorigenic pathways, allowing tumor classification based on which of these endpoints is operating [113,114].”
BackgroundSeimiya, H., Tanji, M., Oh‐hara, T., Tomida, A., Naasani, I., & Tsuruo, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0910 · Cited by 105
Molecular Epidemiology of Primary Brain Tumors
Gu, J., Liu, Y., Kyritsis, A. P., & Bondy, M. L. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.05.001 · Cited by 94
“Rare genetic disorders such as Li-Fraumeni syndrome, neurofibromatosis (NF) type 1 and type 2, tuberous sclerosis, Turcot’s syndrome, and familial polyposis support inherited predisposition to PBTs.(12-14) Comparative genomic hybridization (CGH) analysis of familial PBTs aimed to reveal disease-spe-”
BackgroundExtrachromosomal driver mutations in glioblastoma and low-grade glioma
Nikolaev, S. I., Santoni, F. A., Garieri, M., Makrythanasis, P., Falconnet, E., Guipponi, M., Vannier, A., Radovanovic, I., Béna, F., Forestier, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms6690 · Cited by 96
The genomically mosaic brain: Aneuploidy and more in neural diversity and disease
Bushman, D. M., & Chun, J. (2013) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2013.02.003 · Cited by 93
“Such changes have been correlated with cancers, such as the loss of chromosome 10, gain of chromosome 7 or chromosome 1p and 19q deletions in human gliomas [55, 57, 92-95], as well as the identification of cancer related genes on the most common aneuploid chromosomes in hESC culture [88, 96, 97].”
BackgroundBaldinu, P., Cossu, A., Manca, A., Satta, M. P., Sini, M. C., Rozzo, C., Dessole, S., Cherchi, P. L., Gianfrancesco, F., Pintus, A., et al. (2004) · Human Mutation · doi:10.1002/humu.20015 · Cited by 93
“Replication errors could represent a consequence of functional alterations of mismatch repair genes [Kinzler and Vogelstein, 1998; Lengauer et al., 1998].”
BackgroundBreast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights
Ng, C. K. Y., Schultheis, A. M., Bidard, F., Weigelt, B., & Reis-Filho, J. S. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv015 · Cited by 112
“Consistent with the notion of chromosomal and microsatellite instability in colorectal cancers, where tumors with microsatellite instability have limited chromosomal instability and vice versa (87), tumors with high numbers of mutations have been recently shown not to have many CNAs and those with many CNAs not to hav…”
BackgroundYin, X. Y., Grove, L. E., Datta, N. S., Katula, K. S., Long, M. W., & Prochownik, E. V. (2001) · PubMed · Cited by 93
LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12–21
Ruivenkamp, C. A. L., Hermsen, M. A. J. A., Postma, C., Klous, A. M., Baak, J. P. A., Meijer, G. A., & Démant, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206246 · Cited by 93
“Oncogene (2003) 22, 3472–3474. doi:10.1038/sj.onc.1206246 Keywords: PTPRJ; colorectal cancer; LOH; CGH; 18q12–21 The successive accumulation of chromosomal imbalances such as losses and gains is a common feature in the progression of colorectal tumors (Lengauer et al., 1998).”
BackgroundInfluentialNagler, A., Korenstein-Ilan, A., Amiel, A., & Avivi, L. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2003.09.007 · Cited by 93
Clustered DNA damage leads to complex genetic changes in irradiated human cells.
Singleton, B. K., Griffin, C. S., & Thacker, J. (2002) · PubMed · Cited by 107
Wang, H., Wu, W., Wang, H.-W., Wang, S., Chen, Y., Zhang, X., Yang, J., Zhao, S., Ding, H.-F., & Lu, D. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop074 · Cited by 93
“I t is now generally accepted that genomic instability plays an important role in the development of various types of cancers.(1) Malignant gliomas, the most common and devastating primary brain tumors in adults,(2) are thought to develop as the result of a gradual accumulation of multiple genetic aberrations includin…”
BackgroundThe optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer
Komarova, N. L., & Wodarz, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401943101 · Cited by 93
Paige, A. J. W., Taylor, K. J., Stewart, A., SGOUROS, J. G., Gabra, H., Sellar, G., Smyth, J. F., Porteous, D. J., & Watson, J. E. V. (2000) · PubMed · Cited by 111
Ruszkiewicz, A. R., Bennett, G., Moore, J., Manavis, J., Rudzki, B., Shen, L. Y. C., & Suthers, G. (2002) · Pathology · doi:10.1080/0031302021000035965-2 · Cited by 92
“It is now accepted that colorectal cancer (CRC) develops through at least two major molecular pathogenic pathways: chromosomal instability (CIN) and microsatellite instability (MSI).(1) The mechanisms underlying CIN are only beginning to be understood.”
BackgroundIntrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
Bianco, R., Troiani, T., Tortora, G., & Ciardiello, F. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00999 · Cited by 98
Genotoxicity of steroidal estrogens
Russo, J., & Russo, I. H. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.05.007 · Cited by 104
“11 Lengauer, C. et al. (1998) Genetic instabilities in human cancers.”
BackgroundZhou, X. C., Mok, S. C., Chen, Z., Li, Y., & Wong, D. W. (2004) · Human Genetics · doi:10.1007/s00439-004-1163-1 · Cited by 90
“Most human cancers are characterized by genetic instabilities (Lengauer et al. 1998).”
BackgroundTreatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution
Venkatesan, S., Swanton, C., Taylor, B. S., & Costello, J. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026617 · Cited by 106
“2011), tumor progression within colorectal cancer (Lengauer et al. 1998; Carter et al. 2006), and worse patient prognosis if CIN is in an optimal range (Birkbak et al.”
BackgroundMagnetic particle targeting for diagnosis and therapy of lung cancers
Saadat, M., Manshadi, M. K. D., Mohammadi, M., Zare, M. J., Zarei, M., Kamali, R., & Sanati‐Nezhad, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.017 · Cited by 93
Bie, F., Wang, Z., Li, Y., Guo, W., Hong, Y., Han, T., Lv, F., Yang, S., Li, S., Li, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41774-w · Cited by 108
Novel antibodies as anticancer agents
Zafir‐Lavie, I., Michaeli, Y., & Reiter, Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210372 · Cited by 109
“because of the high frequency of mutations, chromosomal translocation, gene amplification and utilization of alternative transcriptional and translational mechanisms (Lengauer et al., 1998; Cahill et al., 1999).”
BackgroundEfficiency of carcinogenesis with and without a mutator mutation
Beckman, R. A., & Loeb, L. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606271103 · Cited by 99
Kienitz, A., Vogel, C., Morales, I., Müller, R., & Bastians, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208589 · Cited by 92
“Partial downregulation of spindle checkpoint in human cancer Obvious candidate genes that might be involved in causing CIN in cancer are the spindle checkpoint genes, but these appear to be rarely inactivated by mutation in human cancer (Cahill et al., 1998; Nomoto et al., 1999; Takahashi et al., 1999; Hernando et al.…”
BackgroundInfluentialCentromere-localized breaks indicate the generation of DNA damage by the mitotic spindle
Guerrero, A. A., Gamero, M. C., Trachana, V., Fütterer, A., Pacios-Bras, C., Díaz-Concha, N. P., Cigudosa, J. C., Martínez‐A, C., & van Wely, K. H. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912143106 · Cited by 106
“Another recurrent genetic defect in carcinomas is the loss or gain of complete chromosome arms (41).”
BackgroundProtein kinase A and its role in human neoplasia: the Carney complex paradigm.
Bossis, I., Voutetakis, A., Bei, T. A., Sandrini, F., Griffin, K., & Stratakis, C. A. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110265 · Cited by 93
“Thus, alterations in centrosome function or regulation may result in failure of cell division and/or missegregation of chromosomes (Lengauer et al. 1998, Doxsey 2001).”
BackgroundResultA Genetic Screen for Increased Loss of Heterozygosity inSaccharomyces cerevisiae
Andersen, M. P., Nelson, Z. W., Hetrick, E. D., & Gottschling, D. E. (2008) · Genetics · doi:10.1534/genetics.108.089250 · Cited by 105
Grabsch, H., Dattani, M., Barker, L., Maughan, N., Maude, K., Hansen, O., Gabbert, H. E., Quirke, P., & Mueller, W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2105 · Cited by 91
Molecular evolution of multiple recurrent cancers of the bladder
van Tilborg, A. A. G. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.2973 · Cited by 91
“There are two levels of genetic instability: at the nucleotide level [microsatellite instability (MIN)] and at the chromosome level [chromosome instability (CIN)], the latter being much more frequent in cancer (15).”
BackgroundChromatin organisation and cancer prognosis: a pan-cancer study
Kleppe, A., Albregtsen, F., Vlatkovic, L., Pradhan, M., Nielsen, B., Hveem, T. S., Askautrud, H. A., Kristensen, G. B., Nesbakken, A., Trovik, J., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30899-9 · Cited by 90
Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution
Henriques, A. C., Ribeiro, D. R., Pedrosa, J., Sarmento, B. F. C. C., Silva, P. M. A., & Bousbaa, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.005 · Cited by 98
Phyllodes tumors of the breast segregate in two groups according to genetic criteria
Lae, M. E., Vincent‐Salomon, A., Savignoni, A., Huon, I., Fréneaux, P., Sigal‐Zafrani, B., Aurias, A., Sastre‐Garau, X., & Couturier, J. (2007) · Modern Pathology · doi:10.1038/modpathol.3800756 · Cited by 90
“Genomic amplification is clearly associated with tumor progression in human cancer and occurs lately during tumorigenesis”
BackgroundMutant KRAS, chromosomal instability and prognosis in colorectal cancer
Castagnola, P., & Giaretti, W. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.06.003 · Cited by 99
Carcinogenesis, cancer therapy and chemoprevention
Blagosklonny, M. V. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401610 · Cited by 104
“Genetic instability and mutagenic agents provide mutation repertoire.(7,8) But what is the driving force for”
BackgroundUsing naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology
Pang, L. Y., & Argyle, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.010 · Cited by 109
“Hence telomere dysfunction can initiate a cascade of chromosomal gains, losses and translocations, creating novel chromosomal variants with each cell division [81,82].”
BackgroundGisselsson, D., Jonson, T., Yu, C., Martins, C., Mandahl, N., Wiegant, J. C. A. G., Jin, Y., Mertens, F., & Jin, C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600438 · Cited by 104
“Though several different modes of chromosomal instability have been reported, the underlying molecular mechanisms are poorly known (Lengauer et al, 1998).”
BackgroundDNA Damage-induced Inhibition of Securin Expression Is Mediated by p53
Zhou, Y., Mehta, K. R., Choi, A., Scolavino, S., & Zhang, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203793200 · Cited by 98
Recent advances in cancer research: mouse models of tumorigenesis
Herzig, M., & Christofori, G. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00039-2 · Cited by 101
Ohshima, K., Haraoka, S., Yoshioka, S., Hamasaki, M., FUJIKI, T., Suzumiya, J., Kawasaki, C., Kanda, M., & Kikuchi, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00512-7 · Cited by 101
Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
Grushko, T. A., Blackwood, M. A., Schumm, L. P., Hagos, F., Adeyanju, M., Feldman, M. D., Sanders, M. O., Weber, B. L., & Olopade, O. I. (2002) · PubMed · Cited by 88
Friedberg, E. C., Bond, J. P., Burns, D. K., Cheo, D. L., Greenblatt, M. S., Meira, L. B., Nahari, D., & Reis, A. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00068-3 · Cited by 100
Konishi, H., Karakas, B., Abukhdeir, A. M., Lauring, J., Gustin, J. P., Garay, J. P., Konishi, Y., Gallmeier, E., Bachman, K. E., & Park, B. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0108 · Cited by 89
“In addition, the cancer cell lines used in the K-ras knockout studies display an unusually high rate of mutation known as microsatellite instability (MIN), a genetically unstable phenotype caused by mutations or silencing of nucleotide mismatch repair genes (49).”
BackgroundTanaka, M., Kyo, S., Kanaya, T., Yatabe, N., Nakamura, M., Maida, Y., Okabe, M., & Inoue, M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63653-x · Cited by 90
Patterns of Genomic Instability in Breast Cancer
Kalimutho, M., Nones, K., Srihari, S., Duijf, P. H. G., Waddell, N., & Khanna, K. K. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.005 · Cited by 102
Peloponese, J.-M., Haller, K., Miyazato, A., & Jeang, K.-T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506659103 · Cited by 88
Transcription factors and cancer: an overview
Nebert, D. W. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00269-x · Cited by 112
Linear Model of Colon Cancer Initiation
Michor, F., Iwasa, Y., Rajagopalan, H., Lengauer, C., & Nowak, M. A. (2004) · Cell Cycle · doi:10.4161/cc.3.3.690 · Cited by 102
Urothelial Tumors of the Bladder
Wood, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00080-3 · Cited by 95
Role of chromosomal instability in cancer progression
McClelland, S. E. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0187 · Cited by 96
Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases
Knösel, T., Petersen, S., Schwabe, H., Schlüns, K., Stein, U., Schlag, P., Dietel, M., & Petersen, I. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100493 · Cited by 88
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 90
“In agreement, cancer is associated with genetic instability [59, 62-69].”
BackgroundEvolving concepts of tumor heterogeneity
Zellmer, V. R., & Zhang, S. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-69 · Cited by 105
“However, the specific mechanisms and precise order in which they occur have yet to be elucidated [21].”
BackgroundStolfi, C., Simone, V. D., Pallone, F., & Monteleone, G. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917972 · Cited by 103
“Aspirin (2.5 mM) and sulindac (400 µM) reduce MSI in human CRC cells that lack DNA MMR activity [45].”
BackgroundInfluentialCudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
Shin, H.-J., Baek, K., Jeon, A.-H., Kim, S., Jang, K., Sung, Y., Kim, C., & Lee, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206502 · Cited by 87
“…on each duplicated chromosome pair have successfully attached to the spindle microtubules and are under adequate tension, thus preventing the chromosome instability and polyploidy associated with cancer (Lengauer et al., 1998; Rieder and Salmon, 1998; Amon, 1999; Wassmann and Benezra, 2000).”
BackgroundInfluentialCatto, J. W. F., Xinarianos, G., Burton, J. L., Meuth, M., & Hamdy, F. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11109 · Cited by 87
Oncogene-induced plasticity and cancer stem cells
Rapp, U. R., Ceteci, F., & Schreck, R. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5203 · Cited by 98
“This may lead to other lung cell types (1,2) or to cells mimicking the phenotype of cells from the primitive gut tube (3,4).”
BackgroundMoniaux, N., Némos, C., Schmied, B. M., Chauhan, S. C., Deb, S., Morikane, K., Choudhury, A., VanLith, M. L., Sutherlin, M. E., Sikela, J. M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209353 · Cited by 88
“They are often stabilized when they confer a growth or survival advantage to the cells (Lengauer et al., 1998).”
BackgroundChromosome instability in cancer:how, when, and why?
Gisselsson, D. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87293-7 · Cited by 87
A mechanism of palindromic gene amplification in Saccharomyces cerevisiae
Rattray, A. J., Shafer, B. K., Neelam, B. A., & Strathern, J. N. (2005) · Genes & Development · doi:10.1101/gad.1315805 · Cited by 93
“Gene amplification is also associated with abnormal processes, such as increased drug resistance (Schimke et al. 1978; Paquin et al. 1992) and the onset and progression of tumorigenesis (Lengauer et al. 1998).”
BackgroundMinari, J. B., & Okeke, U. V. (2014) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2014.05.001 · Cited by 114
Aróstegui, J. I., Saldaña, M. D. L., Pascal, M., Clemente, D., Aymerich, M., Balaguer, F., Goel, A., del Castillo, C. F., Rius, J., Plaza, S., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27342 · Cited by 85
Morisawa, T., Marusawa, H., Ueda, Y., Iwai, A., Okazaki, I., Honjo, T., & Chiba, T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23853 · Cited by 92
Clonal and non-clonal chromosome aberrations and genome variation and aberration
Heng, H. H., Liu, G., Bremer, S. W., Ye, K. J., Stevens, J. B., & Ye, C. J. (2006) · Genome · doi:10.1139/g06-023 · Cited by 92
“The majority of cancers display chromosomal abnormalities (Lengauer et al. 1998; Heppner and Miller 1998; Cahill et al. 1999; Rajagopalan and Lengauer 2004; Heng et al. 2004b; Duesberg 2005).”
BackgroundDorer, R. K., Zhong, S., Tallarico, J. A., Wong, W. H., Mitchison, T. J., & Murray, A. W. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.020 · Cited by 86
“Some tumors are deective for the spindle checkpoint and carry mutations n hBUB1, whereas many others have a functional spinle checkpoint [35].”
Overexpression of Polo-Like Kinase 1 (PLK1) and Chromosomal Instability in Bladder Cancer
Yamamoto, Y., Matsuyama, H., Kawauchi, S., Matsumoto, H., Nagao, K., Ohmi, C., Sakano, S., Furuya, T., Oga, A., Naito, K., et al. (2006) · Oncology · doi:10.1159/000094416 · Cited by 86
Lin, L., Bass, A. J., Lockwood, W. W., Wang, Z., Silvers, A. L., Thomas, D. G., Chang, A. C., Lin, J., Orringer, M. B., Li, W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011989109 · Cited by 90
“Gene amplification is one mechanism for the activation of oncogenes, and this activation can be causative for tumorigenesis (10, 11).”
BackgroundKing, T. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.311 · Cited by 87
Mutant p53: Gain-of-Function Oncoproteins and Wild-Type p53 Inactivators
Roemer, K. (1999) · Biological Chemistry · doi:10.1515/bc.1999.108 · Cited by 86
“Polyploidy, aneuploidy, and gene amplification frequently correlate with the presence of mutant p53, for instance in common colon cancers (for an overview, see Lengauer et al., 1998).”
BackgroundBettstetter, M., Woenckhaus, M., Wild, P. J., Rümmele, P., Blaszyk, H., Hartmann, A., Hofstädter, F., & Dietmaier, W. (2005) · The Journal of Pathology · doi:10.1002/path.1732 · Cited by 85
“Eightyfive percent of CRC show frequent aneuploidy and gross chromosomal alterations (chromosomal instability, CIN [30]), whereas 15% of all CRC develop through a mutator phenotype with loss of expression of mismatch repair proteins leading to highfrequency microsatellite instability (MSI-H).”
BackgroundChromosomal instability in osteosarcoma and its association with centrosome abnormalities
Al-Romaih, K. I., Bayani, J., Vorobyova, J., Karásková, J., Park, P. C., Zieleńska, M., & Squire, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00929-9 · Cited by 86
Gladdy, R. A., Taylor, M. D., Williams, C. J., Grandal, I., Karásková, J., Squire, J. A., Rutka, J. T., Guidos, C. J., & Danska, J. S. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00236-2 · Cited by 94
Ouyang, K. J., Woo, L. L., & Ellis, N. A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.03.003 · Cited by 105
Mitochondria as determinant of nucleotide pools and chromosomal stability
Desler, C., Munch‐Petersen, B., Stevnsner, T., Matsui, S., Kulawiec, M., Singh, K. K., & Rasmussen, L. J. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.06.002 · Cited by 93
New trends in molecular and cellular biomarker discovery for colorectal cancer
Aghagolzadeh, P., & Radpour, R. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5678 · Cited by 95
The SCF ubiquitin ligase protein Slimb regulates centrosome duplication in Drosophila
Wojcik, E. J., Glover, D. M., & Hays, T. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00703-x · Cited by 101
“instability [1–3] and are a hallmark of certain transformed”
The role of the centrosome in the development of malignant tumors
Lingle, W. L., & Salisbury, J. L. (1999) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(99)49015-5 · Cited by 85
Isothiocyanates: a class of bioactive metabolites with chemopreventive potential
Kumar, G., Tuli, H. S., Mittal, S., Shandilya, J. K., Tiwari, A., & Sandhu, S. S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3391-5 · Cited by 84
“They have become a suitable target of anti-tumor drugs [89], as the interference with microtubule dynamics arrests cell cycle progression and results in apoptosis [90, 91].”
BackgroundInduction of genome instability by DNA damage in Saccharomyces cerevisiae
Myung, K., & Kolodner, R. D. (2003) · DNA repair · doi:10.1016/s1568-7864(02)00216-1 · Cited by 99
Hill, D. A., O’Sullivan, M. J., Zhu, X., Vollmer, R. T., Humphrey, P. A., Dehner, L. P., & Pfeifer, J. D. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200208000-00001 · Cited by 84
Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma
Xie, D., Sham, J. S. T., Zeng, W.-F., Lin, H.-L., Bi, J., Che, L.-H., Hu, L., Zeng, Y.-X., & Guan, X. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.007 · Cited by 90
Cancer progression by non‐clonal chromosome aberrations
Heng, H. H., Bremer, S. W., Stevens, J. B., Ye, K. J., Miller, F. W., Liu, G., & Ye, C. J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20964 · Cited by 84
“Our arguments are additionally supported by the arguments of others [Duesberg, 2005; Miklos, 2005], and by the fact that most cancers involve chromosomal instability [Atkin and Baker, 1990; Lengauer et al., 1998; Albertson et al., 2003] and chromosomal aberrations thus represent universal features of cancer.”
BackgroundResultPiao, Z. H., Fang, W., Malkhosyan, S. R., Kim, H., Horii, A., Perucho, M., & Huang, S. (2000) · PubMed · Cited by 84
Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project
Bakhoum, M. F., & Esmaeli, B. (2019) · Cancers · doi:10.3390/cancers11081061 · Cited by 94
“Consequently, genomic heterogeneity can facilitate tumor evolution [44,46].”
BackgroundChen, Z., Lu, T., Huang, L., Wang, Z., Yan, Z., Guan, Y., Hu, W., Fan, Z., & Zhu, P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148020 · Cited by 91
“Compared with normal cells, tumor cells harbor more unstable chromosomes with frequent mutations and gene CNA, 2 common chromosome aberrations detected in tumors (48, 49).”
BackgroundWhole chromosome loss is promoted by telomere dysfunction in primary cells
Pampalona, J., Soler, D., Genescà, A., & Tusell, L. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20749 · Cited by 98
“This chromosomal instability (CIN), which can be defined as the continuous formation of new structural and numerical chromosome aberrations, is one of the most frequent forms of instability in human cancers (Lengauer et al., 1998).”
BackgroundDiscovery of time-delayed gene regulatory networks based on temporal gene expression profiling
Li, X., Rao, S., Jiang, W., Li, C., Xiao, Y., Guo, Z., Zhang, Q., Wang, L., Du, L., Li, J., et al. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-26 · Cited by 91
“[54] showed that the two genes have roles in centrosome duplication, whose improper expression is a potential cause of tumor aneuploidy.”
Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas
Ishiguro, K., Yoshida, T., Yagishita, H., Numata, Y., & Okayasu, T. (2005) · Gut · doi:10.1136/gut.2005.079459 · Cited by 83
Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer
Iwaizumi, M., Shinmura, K., Mori, H., Yamada, H., Suzuki, M., Kitayama, Y., Igarashi, H., Nakamura, T., Suzuki, H., Watanabe, Y., et al. (2008) · Gut · doi:10.1136/gut.2008.149468 · Cited by 92
“In colorectal cancer progression, two forms of genomic instability have been identified: microsatellite instability (MIN) and chromosomal instability (CIN).(1) 2 MIN is generally due to”
Background
Metadata
- Authors
- Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6712
- Pages
- 643-649
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1544851750
- Cited by
- 4,168
- References
- 98
- Citations by year
- 2026: 18 · 2025: 44 · 2024: 56 · 2023: 74 · 2022: 83 · 2021: 91 · 2020: 92 · 2019: 90 · 2018: 99 · 2017: 106 · 2016: 113 · 2015: 136 · 2014: 145 · 2013: 156 · 2012: 183
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- genomic instability, carcinogenesis, chromosomal instability, microsatellite instability, base substitutions, chromosomal deletion, chromosomal gains, cancer genetics
- MeSH terms
- Chromosome Aberrations, Gene Amplification, Humans, Neoplasms, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.